Immunoclin Limited
03914021
Some Concerns
- Negative net worth (-10)
- Current liabilities exceed current assets (-10)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
secretary · Since 10/12/2002
COMPANY SECRETARY
BRITISH · Age 75
Also on 1 other board
director · Since 04/10/2013
COMPANY SECRETARY
BRITISH · ENGLAND · Age 75
Also on 1 other board
Persons with Significant Control
Dr Dorothy H Bray
2, Royal College Street, London, NW1 0NH
Notified 06/04/2016
Former PSCs
Maitland Pharma Corp
Ceased 23/01/2022
CompanyRankvs 266+ SIC 21200 peers43
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 28/02/2025
Net Worth
-£226k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
-£267k
Working capital
Current Assets
£20k
Current Liabilities
£287k
Fixed Assets
£40k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 0.07 | -£16k |
| 2024 | 0.25 | +£33k |
| 2023 | 0.16 | -£12k |
| 2022 | 0.22 | +£287 |
| 2021 | 0.23 | +£107k |
| 2020 | 0.06 | -£61k |
| 2019 | 0.07 | — |
Derived from filed accounts. Not audited figures.